Livmor®
AI Native1 Agent. 10× Impact. 0 Admin. | AI-Powered Medicare Automation | Helping Seniors Worry Less and Live More
Est 2023
Published Jun 25, 2026
Public marketing and resource pages did not include an explicit limitations page. The vendor materials are generally promotional in nature and do not enumerate product constraints in detail.
Public press materials referenced specific feature launches and integrations tied to enrollment cycles; dates and timelines in vendor materials should be treated as vendor-stated and verified in procurement discussions.
Scale characteristics (concurrent user limits, throughput SLAs) were not publicly documented.
Public materials did not disclose a complete API surface, integration list, or partner ecosystem details sufficient to certify enterprise-grade integration capabilities. Procurement should request an integration matrix and API documentation during technical evaluation.
The vendor name overlaps with other historical brands that have used the same or a similar name. This can complicate background checks unless searches are scoped specifically to the Medicare automation vendor (livmor.ai).
Vendor-specific listings and third-party user reviews were not identified on common review platforms during this research run. Attempts to locate Livmor product reviews on major review sites did not return confirmed, accessible vendor-specific review pages.
Direct community discussions specifically about this vendor or AgentIQ were not surfaced in the search results analyzed for this report.
Because third-party user-review coverage was limited in the accessible crawl, there is restricted publicly available evidence to balance vendor claims with independent user feedback. Prospective buyers should request customer references, retention metrics, service-level agreements, and pilot data as part of procurement diligence.
A case study exists that describes Livmor's use of a third-party AI platform (Skypoint) as part of its operations. That case study primarily documents a relationship or technology usage rather than independently verified outcomes for Livmor customers. It can provide context on integrations and vendor architecture choices but should not be interpreted as direct evidence of customer ROI.
Get a comprehensive analysis of Livmor® including market position, competitive landscape, adoption trends, and peer benchmarks.
Download full report →Public vendor materials describe AgentIQ as an AI-powered plan research and comparison tool with features such as compliance guidance and portfolio analysis for identifying at-risk customers. The vendor also promotes immediate plan detail access and personalized plan matching in marketing materials; these are vendor-stated features rather than independently verified outcomes.
A trade publication included the vendor in a product recognition list; this should be treated as media coverage rather than a quantified measure of return on investment.
Vendor press materials assert that AgentIQ is supported by an extensive Medicare plan data repository and that the product improves speed and accuracy in agent workflows. These claims were not accompanied by disclosed methodologies, sample sizes, or independent audits in the materials reviewed; procurement should request measurable before/after metrics for named customers if vendor impact claims are a key procurement criterion.
Questions to request from the vendor to validate case study claims:
Livmor (vendor product pages) is a vendor-described AI-enabled Medicare agent automation and intelligence platform. The product is intended to help Medicare agents and agencies research and compare plans, answer client questions, manage compliance workflows, and reduce administrative work associated with enrollment and retention.
A prominent product name in the vendor materials is AgentIQ (a tool for plan research, comparison, and workflow automation). The vendor has published claims of substantial increases in enrollments and of significantly higher agent throughput; these are vendor-stated claims and public, independent validation of those specific performance claims was not identified in the accessible materials reviewed for this report.